Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (1051-1060 of 1,060) with videos related to

Pageof 106
Sort By:
You have reached the last page of results.This site can display upto 1,060 results.
Circulation. Heart Failure|April 19, 2021
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialJasper Tromp, Brian L Claggett, Jiankang Liu, et al.
Journal of the American Heart Association|June 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic SubstudyNatasha L Patel-Murray, Luqing Zhang, Brian L Claggett, et al.
Circulation|September 23, 2024
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF TrialGregg W Stone, JoAnn Lindenfeld, Josep Rodés-Cabau, et al.
European Journal of Heart Failure|December 17, 2021
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fractionAlice M Jackson, Rasmus Rørth, Jiankang Liu, et al.
The New England Journal of Medicine|September 3, 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott D Solomon, John J V McMurray, Inder S Anand, et al.
Science in One Health|July 30, 2024
How far has the globe gone in achieving One Health? Current evidence and policy implications based on global One Health indexQiyu Zhang, Jingshu Liu, Lefei Han, et al.
European Heart Journal|November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failureJohn McMurray, Milton Packer, Akshay Desai, et al.
JACC. Heart Failure|March 20, 2023
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection FractionSheldon E Litwin, Jan Komtebedde, Mo Hu, et al.
Circulation|November 19, 2014
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failureMilton Packer, John J V McMurray, Akshay S Desai, et al.
Circulation. Heart Failure|July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Pageof 106

Showing results (1051-1060 of 1,060) with videos related to

Sort By:
Pageof 106
You have reached the last page of results.This site can display upto 1,060 results.
Circulation. Heart Failure|April 19, 2021
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF TrialJasper Tromp, Brian L Claggett, Jiankang Liu, et al.
Journal of the American Heart Association|June 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic SubstudyNatasha L Patel-Murray, Luqing Zhang, Brian L Claggett, et al.
Circulation|September 23, 2024
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF TrialGregg W Stone, JoAnn Lindenfeld, Josep Rodés-Cabau, et al.
European Journal of Heart Failure|December 17, 2021
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fractionAlice M Jackson, Rasmus Rørth, Jiankang Liu, et al.
The New England Journal of Medicine|September 3, 2019
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott D Solomon, John J V McMurray, Inder S Anand, et al.
Science in One Health|July 30, 2024
How far has the globe gone in achieving One Health? Current evidence and policy implications based on global One Health indexQiyu Zhang, Jingshu Liu, Lefei Han, et al.
European Heart Journal|November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failureJohn McMurray, Milton Packer, Akshay Desai, et al.
JACC. Heart Failure|March 20, 2023
Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection FractionSheldon E Litwin, Jan Komtebedde, Mo Hu, et al.
Circulation|November 19, 2014
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failureMilton Packer, John J V McMurray, Akshay S Desai, et al.
Circulation. Heart Failure|July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Pageof 106